Abstract
Non-mesenchymal pancreatic cells are a potential source for cell replacement.
Their transdifferentiation can be achieved by triggering epigenetic remodeling
through e. g. post-translational modification of histones. Valproic
acid, a branched-chain saturated fatty acid with histone deacetylase inhibitor
activity, was linked to the expression of key transcription factors of
pancreatic lineage in epithelial cells and insulin transcription. However, the
potential of valproic acid to cause cellular reprogramming is not fully
understood. To shed further light on it we employed next-generation RNA
sequencing, real-time PCR, and protein analyses by ELISA and western blot, to
assess the impact of valproic acid on transcriptome and function of
Panc-1-cells. Our results indicate that valproic acid has a significant impact
on the cell cycle, cell adhesion, histone H3 acetylation, and metabolic pathways
as well as the initiation of epithelial-mesenchymal transition through
acetylation of histone H3 resulting in α-cell-like characteristics. We
conclude that human epithelial pancreatic cells can be transdifferentiated into
cells with endocrine properties through epigenetic regulation by valproic acid
favoring an α-cell-like phenotype.
Key words
pancreas - epigenetics - epithelial–mesenchymal transition